12-year old boy receives unapproved 3rd, develops swollen lymph nodes and chills

The adult dose of Moderna has not been approved for children/teens. And I don’t think this kid was supposed to get double vaxxed with Pfizer because it wasn’t approved at the time. But thanks to human ingenuity or something, this kid’s parents managed to get the kid triple vaxxed. The third vax was Moderna, which still isn’t approved for kids.

OpenVAERS 2097322

The recipient of this vaccine is 12 years old.; Inflamed lymph nodes under his arm; Chills; This spontaneous case was reported by a pharmacist and describes the occurrence of LYMPHADENITIS (Inflamed lymph nodes under his arm), CHILLS (Chills) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (The recipient of this vaccine is 12 years old.) in a 12-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.
Previously administered products included for Product used for unknown indication: Pfizer COVID-19 vaccine (Patient received 2 primary doses of the Pfizer COVID-19 vaccine.).
Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 vaccine. On 29-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter.
In January 2022, the patient experienced LYMPHADENITIS (Inflamed lymph nodes under his arm) and CHILLS (Chills).
On 29-Jan-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (The recipient of this vaccine is 12 years old.). The patient was treated with IBUPROFEN in January 2022 for Chills and Lymph node inflammation, at an unspecified dose and frequency.
On 29-Jan-2022, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (The recipient of this vaccine is 12 years old.) had resolved. At the time of the report, LYMPHADENITIS (Inflamed lymph nodes under his arm) and CHILLS (Chills) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
No concomitants were provided. It was reported that since receiving the booster dose of the vaccine the patient experienced the event and was ongoing at the time of report.